Early Cognitive Behavioral Therapy for Insomnia (CBT-I) in People Planning to Under Hematopoietic Stem Cell Transplant (HSCT)
Part of paid clinical trials in Kansas City, Kansas.
- Sponsor
- University of Kansas Medical Center
- Study ID
- NCT07774039
- Phase
- PHASE1
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Hematopoietic Stem Cell Transplant
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cognitive behavioral therapy for insomnia (CBT-I) — BEHAVIORALThe CBT-I program is a 1x/week, 6-week one-one-one program via video conferencing with trained research personnel. The program is based on standard CBT-I manuals.
Study Details
This proposed study is a prospective, randomized, controlled Phase 1 clinical trial to determine feasibility, acceptability (Aim 1) and preliminary effect (Aim 2) to mitigate insomnia symptoms and fatigue and improve health-related quality of life in patients who are planning to undergo HSCT. The investigators plan to enroll n=30 with insomnia symptoms (Insomnia Severity Index ≥10) who will be randomized into one of two groups: 1. A group that starts CBT-I after the initial evaluation visit with the HSCT care team (Early CBT-I), or 2. Treatment as usual (TAU). Participants in the CBT-I group will receive six sessions of telehealth-delivered CBT-I that is completed prior to transplant. Reassessments will occur post-intervention (\~1-2 weeks before HSCT) and 1- and 3-months post-HSCT.
Key Dates
- First listed
- Aug 19, 2026
- Start date
- Sep 8, 2026
- Status verified
- Aug 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Cognitive behavioral therapy for insomnia (CBT-I)
- No Intervention: Treatment As Usual (TAU)
Primary Outcome Measure
Recruitment [ Time Frame: 1 year ]
Central Contacts
- Catherine Siengsukon, PT, PHD913-588-6913
- Jade Robichaud
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Kansas Medical Center- Sleep, Health and Wellness Laboratory | Kansas City | Kansas | 66160 | Jade Robichaud |
Find similar trials in Kansas City, KS
Related Studies
- T Cell Therapy of Opportunistic Cytomegalovirus InfectionEARLY_PHASE1 · Recruiting · Mari Dallas · Cleveland, Ohio
- Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell TransplantNot Yet Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell TransplantationRecruiting · University of Michigan Rogel Cancer Center · Ann Arbor, Michigan
- Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation SurvivorsRecruiting · Brigham and Women's Hospital · Tampa, Florida